Total versus subtotal hysterectomy for benign gynaecological conditions
- PMID: 16625620
- DOI: 10.1002/14651858.CD004993.pub2
Total versus subtotal hysterectomy for benign gynaecological conditions
Update in
-
Total versus subtotal hysterectomy for benign gynaecological conditions.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004993. doi: 10.1002/14651858.CD004993.pub3. Cochrane Database Syst Rev. 2012. PMID: 22513925
Abstract
Background: Hysterectomy using an abdominal approach removes either the uterus alone (subtotal hysterectomy) or both the uterus and the cervix (total hysterectomy). The latter is more common but outcomes have not been systematically compared.
Objectives: To assess and compare outcomes with subtotal hysterectomy versus total abdominal hysterectomy for benign gynaecological conditions.
Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group's specialised register of controlled trials (December 2005), Central (December 2005), Medline (1966 to December 2005), EmBase (1980 to December 2005), Biological Abstracts (1980 to December 2005), the National Research Register and relevant citation lists.
Selection criteria: Only randomised controlled trials of women undergoing either total or subtotal hysterectomy for benign gynaecological conditions were included.
Data collection and analysis: Three trials that included 733 participants were included. Independent selection of trials and data extraction were undertaken by 2 reviewers and results compared.
Main results: There was no evidence of a difference in the rates of incontinence, constipation or measures of sexual function. In one unblinded trial, a significantly greater proportion of women indicated that they had frequent episodes of urinary incontinence after subtotal hysterectomy when compared with total hysterectomy (OR=2.1, 1.02 to 4.3), but these results were not confirmed by the other two trials that measured both stress and urge incontinence and urinary frequency. . Length of surgery and amount of blood lost during surgery were significantly reduced during subtotal hysterectomy when compared with total hysterectomy, but there was no evidence of a difference in the odds of transfusion. Febrile morbidity was less likely (OR=0.43, 0.25 to 0.75) and ongoing cyclical vaginal bleeding one year after surgery was more likely (OR=11.3, 4.1 to 31.2) after subtotal when compared with total hysterectomy. There was no evidence of a difference in the rates of other complications, recovery from surgery or readmission rates.
Authors' conclusions: This review has not confirmed the perception that subtotal hysterectomy offers improved outcomes for sexual, urinary or bowel function when compared with total abdominal hysterectomy. Surgery is shorter and intraoperative blood loss and fever are reduced but women are more likely to experience ongoing cyclical bleeding up to a year after surgery with subtotal hysterectomy compared to total hysterectomy.
Comment in
-
Total versus subtotal hysterectomy for benign gynaecological conditions.Obstet Gynecol. 2007 Sep;110(3):705-6. doi: 10.1097/01.AOG.0000280283.83502.e8. Obstet Gynecol. 2007. PMID: 17766621 No abstract available.
Similar articles
-
Total versus subtotal hysterectomy for benign gynaecological conditions.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004993. doi: 10.1002/14651858.CD004993.pub3. Cochrane Database Syst Rev. 2012. PMID: 22513925
-
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. doi: 10.1002/14651858.CD002126.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3. PMID: 16235297 Updated.
-
Surgical approach to hysterectomy for benign gynaecological disease.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003677. doi: 10.1002/14651858.CD003677.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2009 Jul 08;(3):CD003677. doi: 10.1002/14651858.CD003677.pub4. PMID: 16625589 Updated.
-
Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.Cochrane Database Syst Rev. 2001;(2):CD000547. doi: 10.1002/14651858.CD000547. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2017 Nov 15;11:CD000547. doi: 10.1002/14651858.CD000547.pub2. PMID: 11405968 Updated.
-
Surgical approach to hysterectomy for benign gynaecological disease.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003677. doi: 10.1002/14651858.CD003677.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003677. doi: 10.1002/14651858.CD003677.pub3. PMID: 15674911 Updated.
Cited by
-
Mesh erosion following abdominal sacral colpopexy in the absence and presence of the cervical stump.Int Urogynecol J. 2013 Jan;24(1):113-8. doi: 10.1007/s00192-012-1845-5. Epub 2012 Jun 21. Int Urogynecol J. 2013. PMID: 22717784
-
Long-Term Outcomes of the Total or Supracervical Hysterectomy (TOSH) Trial.Female Pelvic Med Reconstr Surg. 2010 Jan;16(1):49-57. doi: 10.1097/SPV.0b013e3181cec343. Female Pelvic Med Reconstr Surg. 2010. PMID: 22229107 Free PMC article.
-
Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.Gynecol Oncol. 2017 Apr;145(1):41-49. doi: 10.1016/j.ygyno.2017.02.004. Epub 2017 Feb 17. Gynecol Oncol. 2017. PMID: 28215841 Free PMC article.
-
Pelvic floor symptoms 5 to 14 years after total versus subtotal hysterectomy for benign conditions: a systematic review and meta-analysis.Int Urogynecol J. 2019 Feb;30(2):181-191. doi: 10.1007/s00192-018-3811-3. Epub 2018 Nov 22. Int Urogynecol J. 2019. PMID: 30467762
-
Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review.Cancers (Basel). 2022 Nov 26;14(23):5832. doi: 10.3390/cancers14235832. Cancers (Basel). 2022. PMID: 36497314 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical